比较双抗生素与单抗生素骨水泥在髋关节置换术中的疗效:系统评价与荟萃分析
该系统评价与荟萃分析纳入8项研究共36939例患者,比较双抗生素骨水泥(DALBC)与单抗生素骨水泥(SALBC)在骨水泥型髋关节置换术后手术部位感染(SSI)风险上的差异。结果显示DALBC与显著更低的SSI风险相关(OR 0.64,95%CI 0.47-0.87,P<0.001,I²=26%),亚组分析中半髋关节置换患者获益显著(OR 0.48,95%CI 0.34-0.69,P<0.001),而全髋关节置换及翻修全髋关节置换患者中差异无统计学显著性。作者认为这些发现支持在高风险髋关节置换患者中考虑使用DALBC以优化感染预防与管理。
要点
- DALBC与SALBC相比,骨水泥型髋关节置换术后SSI风险显著更低(OR 0.64,95%CI 0.47-0.87,P<0.001,I²=26%)。
- 半髋关节置换亚组中DALBC的SSI风险显著降低(OR 0.48,95%CI 0.34-0.69,P<0.001)。
- 全髋关节置换及翻修全髋关节置换亚组中DALBC与SALBC的差异未达统计学显著。
核心结论
- 双抗生素骨水泥显著降低骨水泥型半髋关节置换及整体髋关节置换术后的SSI风险。
- 作者认为这些发现支持在高风险髋关节置换患者中考虑使用DALBC以优化感染预防与管理。
研究设计与样本
- 系统评价与荟萃分析,遵循PRISMA指南,检索PubMed、Embase和Cochrane Library数据库自建库至2025年2月。
- 纳入8项研究,共36939例患者,其中5830例接受DALBC,31109例接受SALBC。
- 采用随机效应模型合并数据,使用I²统计量评估异质性,并根据手术类型进行亚组分析。
主要发现
- DALBC组与SALBC组相比,SSI风险显著更低(OR 0.64,95%CI 0.47-0.87,P<0.001,I²=26%)。
- 半髋关节置换亚组中,DALBC组SSI风险显著低于SALBC组(OR 0.48,95%CI 0.34-0.69,P<0.001)。
- 全髋关节置换和翻修全髋关节置换亚组中,DALBC与SALBC的差异未达统计学显著。
关键数值与推荐
- DALBC vs SALBC:OR 0.64(95%CI 0.47-0.87,P<0.001,I²=26%)。
- 半髋关节置换亚组:DALBC vs SALBC的OR 0.48(95%CI 0.34-0.69,P<0.001)。
- 全髋关节置换和翻修全髋关节置换亚组:差异未达统计学显著。
临床怎么用
- 作者认为这些发现支持在高风险髋关节置换患者中考虑使用DALBC以优化感染预防与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compared the effectiveness of dual antibiotic-loaded bone cement (DALBC) with that of single antibiotic-loaded bone cement (SALBC). The purpose was to evaluate the risk of surgical site infections (SSIs) after cemented hip arthroplasty, which included both hemiarthroplasty and total hip arthroplasty. METHODS: A systematic review and meta-analysis, conducted by the rigorous Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, ensured a comprehensive search across PubMed, Embase, and the Cochrane Library databases from inception to February 2025. This thorough process, including subgroup analyses based on procedure type, should instill confidence in the validity of the results. Data were pooled using a random effects model, and heterogeneity was assessed using the I2 statistic. There were eight studies, comprising a total of 36,939 patients included, with 5,830 patients receiving DALBC and 31,109 patients receiving SALBC. RESULTS: The use of DALBC was associated with a significantly lower risk of SSI compared to SALBC (odds ratio: 0.64; 95% confidence interval: 0.47 to 0.87; P < 0.001; I2 = 26%). Subgroup analysis revealed this reduction was significant in hemiarthroplasty patients (odds ratio: 0.48; 95% confidence interval: 0.34 to 0.69; P < 0.001), whereas the difference was not statistically significant in total hip arthroplasty and revision total hip arthroplasty patients. CONCLUSIONS: Dual antibiotic-loaded bone cement significantly reduces the risk of SSI following cemented hip hemiarthroplasty and overall hip arthroplasty. These findings support the consideration of DALBC in high-risk patients undergoing hip arthroplasty to optimize infection prevention and management.
引用
- Mzeihem M, Rteil A, Koh J, et al. Evaluating the Efficacy of Dual Versus Single Antibiotic-Loaded Bone Cement in Hip Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. PMID: 40939941. doi:10.1016/j.arth.2025.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。